The role of glycodelin as an immune-modulating agent at the feto-maternal interface

scientific article

The role of glycodelin as an immune-modulating agent at the feto-maternal interface is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JRI.2009.06.261
P698PubMed publication ID19896207

P2093author name stringAnjali A Karande
Anshula Alok
P433issue1-2
P304page(s)124-127
P577publication date2009-11-05
P1433published inJournal of Reproductive ImmunologyQ15755932
P1476titleThe role of glycodelin as an immune-modulating agent at the feto-maternal interface
P478volume83

Reverse relations

cites work (P2860)
Q33729663Characteristic Changes in Decidual Gene Expression Signature in Spontaneous Term Parturition
Q35177925Correlation of endometrial glycodelin expression and pregnancy outcome in cases with polycystic ovary syndrome treated with clomiphene citrate plus metformin: a controlled study
Q33611653Endocrine factors modulating immune responses in pregnancy
Q91738247Glycodelin As A Biomarker Of Advanced Lung Adenocarcinoma Brain Metastases In Patients Treated With EGFR Tyrosine Kinase Inhibitors
Q60918194Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC
Q57306210Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1/2 breast cancer patients
Q37687605Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma
Q38769518Immune-endocrine crosstalk during pregnancy
Q47261448Immunomodulatory activity of glycodelin: Implications in allograft rejection.
Q38591258Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome
Q43410786Mapping the apoptosis inducing domain of an immunomodulatory protein: glycodelin A.
Q36202227Progesterone and autoimmune disease
Q38164123Relaxin: a missing link in the pathomechanisms of Systemic Lupus Erythematosus?
Q38693497The Pleiotropic Effect of Glycodelin-A in Early Pregnancy.
Q30317628The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape